Frank Lee is the founder of FORMA Therapeutics. Latest round: Series D. Backed by Cormorant Capital, Wellington Management, Samsara BioCapital.
Frank Lee is the founder of FORMA Therapeutics, a biotechnology company focused on developing treatments for sickle cell disease. His company was acquired by Novo Nordisk in September 2024 for $1.1 billion. Lee led FORMA through a $100 million Series D funding round to advance its sickle cell treatment program.
Full founder directory · Investor directory · Company funding database · Fundraising library